News
A Mexico City startup has achieved the Western Hemisphere's first SaMD regulatory approval for its proprietary AI-powered ...
FDA approves Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk groups Phase 3 trial shows mNEXSPIKE outperforms original ...
XENOVIEW™, prepared from the Xenon Xe 129 Gas Blend, is a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and ...
The FDA plans to roll out its agency-wide AI tool weeks ahead of schedule, per a press release that provides the most ...
Brain-computer interface technology shows promise in helping motor-impaired patients, like those with Lou Gehrig's disease, ...
9h
Medical Device Network on MSNFDA grants breakthrough device status to BiVACOR’s artificial heartThe US Food and Drug Administration (FDA) has granted breakthrough device designation to BiVACOR’s titanium Total Artificial ...
A breakthrough nerve therapy is improving stroke survivors' mobility and quality of life. A UConn doctor is asking the state ...
Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...
In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results